| Name | Cvs Pharmacy #17332 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 1 Hawes Way, Stoughton, Massachusetts 02072 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (781) 847-4003 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Gene therapy could be an effective way to improve survival rates among heart attack patients, new research funded by the British Heart Foundation (BHF) suggests. Academics at the University of Bristol found that boosting levels of a natural growth factor in the heart could help the muscle to recover after a heart attack. The death rate from a heart attack was halved in mice that received the treatment.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.
Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non‐invasive blood test that is three times more specific in detecting prostate cancer1 than PSA (prostate‐specific antigen).
A new American Cancer Society study finds progress in reducing cancer death rates is evident whether measured against baseline rates in 1970 or in 1990. The study appears in the open access journal PLos ONE, and finds a downturn in cancer death rates since 1990 results mostly from reductions in tobacco use, increased screening allowing early detection of several cancers, and modest to large improvements in treatment for specific cancers.
Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.
› Verified 9 days ago
| NPI Number | 1700034154 |
| Organization Name | CVS PHARMACY INC. |
| Doing Business As | CVS PHARMACY #17332 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1 Hawes Way, Stoughton, MA 02072 |
| Phone Number | 781-847-4003 |
News Archive
Gene therapy could be an effective way to improve survival rates among heart attack patients, new research funded by the British Heart Foundation (BHF) suggests. Academics at the University of Bristol found that boosting levels of a natural growth factor in the heart could help the muscle to recover after a heart attack. The death rate from a heart attack was halved in mice that received the treatment.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.
Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non‐invasive blood test that is three times more specific in detecting prostate cancer1 than PSA (prostate‐specific antigen).
A new American Cancer Society study finds progress in reducing cancer death rates is evident whether measured against baseline rates in 1970 or in 1990. The study appears in the open access journal PLos ONE, and finds a downturn in cancer death rates since 1990 results mostly from reductions in tobacco use, increased screening allowing early detection of several cancers, and modest to large improvements in treatment for specific cancers.
Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.
› Verified 9 days ago
News Archive
Gene therapy could be an effective way to improve survival rates among heart attack patients, new research funded by the British Heart Foundation (BHF) suggests. Academics at the University of Bristol found that boosting levels of a natural growth factor in the heart could help the muscle to recover after a heart attack. The death rate from a heart attack was halved in mice that received the treatment.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.
Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non‐invasive blood test that is three times more specific in detecting prostate cancer1 than PSA (prostate‐specific antigen).
A new American Cancer Society study finds progress in reducing cancer death rates is evident whether measured against baseline rates in 1970 or in 1990. The study appears in the open access journal PLos ONE, and finds a downturn in cancer death rates since 1990 results mostly from reductions in tobacco use, increased screening allowing early detection of several cancers, and modest to large improvements in treatment for specific cancers.
Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.
› Verified 9 days ago
All Care Home Health Srv Type: Durable Medical Equipment & Medical Supplies Supplier Location: 557 Park St, Stoughton, Massachusetts 02072 Phone: (781) 297-2002 | |
Boston Home Infusion Inc. Type: DME Supplier - Parenteral & Enteral Nutrition Location: 30 Buckley Rd, Stoughton, Massachusetts 02072 Phone: (866) 526-1297 | |
Cvs Pharmacy #02325 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1025 Central St, Stoughton, Massachusetts 02072 Phone: (781) 341-6114 | |
Cvs Pharmacy #17332 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1 Hawes Way, Stoughton, Massachusetts 02072 Phone: (781) 847-4003 | |
Walgreens #5755 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 413 Washington St, Stoughton, Massachusetts 02072 Phone: (781) 344-5600 |